Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.5801
Delayed Data
As of Aug 25
 -0.0206 / -3.43%
Today’s Change
0.46
Today|||52-Week Range
3.38
-52.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2011
Quarter 3
2011
Quarter 4
2011
Quarter 1
2012
Revenue and IncomeNet Revenues1.9M1.2M1.2M1.3M
 
 
 
 
 
Cost of Goods Sold0.000.007.5M5.1M
 
 
 
Depreciation And Amortization18.0K19.0K19.0K19.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.9M1.2M-6.3M-3.8M
 
 
 
 
 
General Expenses6.9M5.3M1.7M1.7M
 
 
 
 
 
Research And Development5.4M3.8M----
 
 
 
Total Operating Expenses6.9M5.3M9.2M6.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.0M-4.1M-8.0M-5.5M
 
 
 
 
 
Extraordinary Charge0.000.00-1.6M0.00
 
 
Other Expenses-1.5M8.6M36.0K-1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.5M4.5M-9.6M-6.9M
 
 
 
 
 
Net Income-6.5M4.5M-9.6M-6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M9.7M9.7M10.2M
 
 
 
 
 
Shares To Calculate EPS Diluted9.7M10.0M9.7M10.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.67$0.45-$0.98-$0.67
 
 
 
 
 
EPS Diluted-$0.67$0.45-$0.98-$0.67